Shandong Keyuan Pharmaceutical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Shandong Keyuan Pharmaceutical Co., Ltd. is a national high-tech enterprise, a core member enterprise of the health industry of Linuo Group, and a backbone enterprise of chemical synthetic drugs in Shandong Province. It is committed to the research and development, production, and sales of chemical raw material drugs, as well as the development of international high-end CMO/CMO business. It has established strategic partnerships with multiple well-known international enterprises. In February 2016, Keyuan Pharmaceutical was successfully listed on the national small and medium-sized enterprise stock transfer system, with stock code 836262. The company has currently obtained domestic GMP certificates, international top certification of the European Union CEP certificate, and international official certifications such as FDA in the United States, Canada, Japan, and South Korea. The main products include metformin hydrochloride, gliclazide, isosorbide mononitrate, isosorbide nitrate, ropivacaine hydrochloride, clarithromycin lactate, lansoprazole, mecobalamin, etc., gradually forming a product pattern that combines five major categories of drugs: hypoglycemic, cardiovascular, cerebrovascular, anesthetic, anti-tumor, and psychiatric, injecting new vitality into the company's future development. The company has a relatively complete production and research and development system. The production plant is located in the Development Zone of Shanghe County, Jinan City, covering an area of over 200 acres. The company has a provincial-level recognized enterprise technology center and a municipal level postdoctoral innovation practice base for research and development, as well as a professional and international research and development team. Committed to becoming the world's best raw material drug supplier, Keyuan Pharmaceutical always adheres to the corporate mission of Linuo Group's "serving the country through industry and pursuing excellence". While maintaining the stable growth of the company's traditional products, it vigorously develops CMO/CMO business, focuses on promoting the industrial layout of characteristic raw materials, and builds Keyuan Pharmaceutical into a first-class domestic and internationally influential company, making greater contributions to the cause of human health. |
| Headquarter | Jinan |
| Establish Date | 12/27/2004 |
| Listed Code | 301281.SZ |
| Listed Date | 4/4/2023 |
| Chairman | Lun Lijun. |
| CEO | Jiang Hongsheng. |
| Website | www.keyuanpharm.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
